Mechanisms regulating c-met overexpression in liver-metastatic B16-LS9 melanoma cells

Journal of Cellular Biochemistry

Volumn 81, Issue 3, 2001, Pages 477-487

  Elia, Giuliano ^a   Ren, Yuan ^a   Lorenzoni, Patrizia ^a   Zarnegar, Reza ^b   Burger, Max M ^a   Rusciano, Dario ^a  

^a FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Agouti; B16 melanoma; C met; HGF SF; MSH

Indexed keywords

AGOUTI PROTEIN; CELL RECEPTOR; INTERMEDIN INHIBITING FACTOR; MELANOCORTIN RECEPTOR; MESSENGER RNA; SCATTER FACTOR RECEPTOR;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL STRAIN; CONTROLLED STUDY; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE REARRANGEMENT; GENETIC TRANSCRIPTION; HALF LIFE TIME; LIVER METASTASIS; MELANOMA B16; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROCESSING; STRAIN DIFFERENCE;

ANIMALS; GENE EXPRESSION REGULATION, NEOPLASTIC; LIVER NEOPLASMS, EXPERIMENTAL; MELANOMA, EXPERIMENTAL; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-MET; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

AGOUTI;

EID: 0035035599     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-4644(20010601)81:3<477::AID-JCB1061>3.0.CO;2-B     Document Type: Article

References (51)

1. Concomitant activation of pathways downstream of Grb2 and PI 3-kinase is required for MET-mediated metastasis
2. Autophosphorylation promotes complex formation of recombinant hepatocyte growth factor receptor with cytoplasmic effectors containing SH2 domains
3. Cortisol inhibits hepatocyte growth factor/scatter factor expression and induces c-met transcripts in osteoblasts
4. A general method for isolation of high molecular weight DNA from eukaryotes
5. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product
6. The melanocortin receptors: Agonists, antagonists, and the hormonal control of pigmentation
7. The high molecular weight isoforms of basic fibroblast growth factor. FGF-2: An insight into an intracrine mechanism
8. Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer
9. Loss and recovery of liver regeneration in rats with fulminant hepatic failure
10. Mitogen-activated protein kinase pathway and AP-1 are activated during cAMP-induced melanogenesis in B-16 melanoma cells
11. Identification of the major autophosphorylation site of the Met/hepatocyte growth factor receptor tyrosine kinase
12. Ets up-regulates MET transcription
13. Structure and inducible regulation of the human MET promoter
14. Transcription factor AP-2 mediates induction by two different signal-transduction pathways: Protein kinase C and cAMP
15. The mutationally activated Met receptor mediates motility and metastasis
16. Autocrine hepatocyte growth factor/scatter factor-Met signaling induces transformation and the invasive/metastastic phenotype in C127 cells
17. Posttranscriptional regulation of gene expression in liver regeneration: Role of mRNA stability
18. C-met activation is necessary but not sufficient for liver colonization by B16 murine melanoma cells
19. Alpha-melanocyte-stimulating hormone immunoreactivity in melanoma cells
20. Role of morphogenetic factors in metastasis of mammary carcinoma cells
21. Liver regeneration
22. Modulation of c-MET proto-oncogene (HGF receptor) mRNA abundance by cytokines and hormones: Evidence for rapid decay of the 8 kb c-MET transcript
23. Interferon-gamma upregulates the c-Met/hepatocyte growth factor receptor expression in alveolar epithelial cells
24. The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomas
25. Expression of the c-Met/ HGF receptor in human melanocytic neoplasms: Demonstration of the relationship to malignant melanoma tumour progression
26. Interaction of Agouti protein with the melanocortin 1 receptor in vitro and in vivo
27. C-met autocrine activation induces development of malignant melanoma and acquisition of the metastatic phenotype
28. The nature of intracrine peptide hormone action
29. Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function
30. Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation
31. Influence of hepatocyte growth factor/scatter factor on the metastatic phenotype of B16 melanoma cells
32. Paracrine growth response as a major determinant in liver-specific colonization by in vivo selected B16 murine melanoma cells
33. Expression of constitutively activated hepatocyte growth factor/scatter factor receptor (c-met) in B 16 melanoma cells selected for enhanced liver colonization
34. Constitutive activation of c-Met in liver metastatic B16 melanoma cells depends on both substrate adhesion and cell density and is regulated by a cytosolic tyrosine phosphatase activity
35. Regulation of c-met expression in B16 murine melanoma cells by melanocyte stimulating hormone
36. Hepatocyte growth factor/scatter factor and hepatocytes are potent downregulators of tyrosinase expression in B16 melanoma cells
37. Mechanisms of metastasis
38. Transcriptional activation of the hepatocyte growth factor receptor (c-met) gene by its ligand (hepatocyte growth factor) is mediated through AP-1
39. Structural and functional characterization of the mouse c-met proto-oncogene (hepatocyte growth factor receptor) promoter
40. Interactions of alpha-melanotropin and agouti on B16 melanoma cells: Evidence for inverse agonism of agouti
41. The roles of hepatocyte growth factor/scatter factor and met receptor in human cancers
42. Clinical significance of c-met oncogene alterations in human colorectal cancer
43. A non-epistatic interaction of agouti and extension in the fox, Vulpes vulpes
44. Expression of the transcription factor c-Ets1 correlates with the occurrence of invasive processes during normal and pathological development
45. The Met receptor tyrosine kinase transduces motility, proliferation, and morphogenic signals of scatter factor/hepatocyte growth factor in epithelial cells
46. Stromal expression of c-Ets1 transcription factor correlates with tumor invasion
47. Hepatocyte growth factor and Met/HGF receptors in patients with gastric adenocarcinoma
48. AP2 inhibits cancer cell growth and activates p21WAF1/CIP1 expression
49. Expression of alpha-melanocyte stimulating hormone and the invasive ability of the B16 murine melanoma